The Centre for Innovation in Regulatory Science (CIRS) is a neutral, independent organisation conducting novel research, convening international forums for healthcare stakeholders and providing science-based insights to advance global regulatory and HTA policies and enhance patient access to medicines.
The assessment of quality decision making in one of three settings. From Bujar M et al. Assessment of the ten quality decision-making practices; case studies with a pharmaceutical company, a regulatory and an HTA agency. DIA, 2018.